Flublok Purple Book BLA 125285

BLA number
125285
Proprietary names
Flublok
Proper names
Influenza Vaccine
Applicant
Protein Sciences Corporation
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001FlublokInfluenza Vaccine351(a)135UG/.5MLInjectionIntramuscularSingle-Dose VialRxLicensed2013-01-16
002FlublokInfluenza Vaccine351(a)180UG/.5MLInjectionIntramuscularPre-Filled SyringeRxLicensed2016-10-07
003FlublokInfluenza Vaccine351(a)135UG/.5MLInjectionIntramuscularPre-Filled SyringeRxLicensed2024-03-04

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2024-08-01N003Flublok351(a)RxProtein Sciences Corporation
2024-07-01U001Flublok351(a)RxProtein Sciences Corporation
2024-02-01U001Flublok351(a)RxProtein Sciences Corporation
2021-05-01U001Flublok351(a)DiscProtein Sciences Corporation
2021-05-01U002Flublok351(a)RxProtein Sciences Corporation
2020-08-01R001Flublok351(a)DiscProtein Sciences Corporation
2020-08-01R002Flublok351(a)RxProtein Sciences Corporation

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2024-08-01003Flublok351(a)RxLicensed2024-03-04
2024-02-01001Flublok351(a)RxLicensed2013-01-16
2020-08-01001Flublok351(a)DiscLicensed2013-01-16
2020-08-01002Flublok351(a)RxLicensed2016-10-07